Antimicrobial effects of nanofiber poly(caprolactone) tissue scaffolds releasing rifampicin

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 6, 2012, Pages 1411-1420

  Ruckh, Timothy T ^a   Oldinski, Rachael A ^b   Carroll, Derek A ^a   Mikhova, Krasimira ^b   Bryers, James D ^b   Popat, Ketul C ^a  

^a Department of Mechanical Engineering   (United States)

^b University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-MICROBIAL EFFECTS; ANTIBIOTIC RELEASE; BACTERIAL GROWTH; BIOFILM FORMATION; CELL POPULATIONS; EPIDERMIDIS; FIBER DIAMETERS; FLUORESCENT MICROSCOPY; GRAM-NEGATIVE BACTERIA; IN-VITRO; LOGARITHMIC GROWTH; MASS LOADINGS; P.AERUGINOSA; PSEUDOMONAS AERUGINOSA; RELEASE KINETICS; STAPHYLOCOCCUS EPIDERMIDIS; STATIC CONDITIONS; TISSUE SCAFFOLDS;

ANTIBIOTICS; BACTERIA; BIOFILMS; CELL CULTURE; CELL PROLIFERATION; KINETICS; LOADING; SCANNING ELECTRON MICROSCOPY; TISSUE;

SCAFFOLDS (BIOLOGY);

NANOFIBER; POLYCAPROLACTONE; RIFAMPICIN; TISSUE SCAFFOLD;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BIOFILM; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RELEASE; ELECTROSPINNING; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPE; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOCOMPATIBLE MATERIALS; BIOFILMS; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; POLYESTERS; PROSTHESIS-RELATED INFECTIONS; PSEUDOMONAS AERUGINOSA; RIFAMPIN; STAPHYLOCOCCUS EPIDERMIDIS; TISSUE SCAFFOLDS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84863305099     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4609-3     Document Type: Article

References (50)

1. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23(7):984-91.
2. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746-51. (Pubitemid 41061193)
3. Mont M, Waldman B, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection: a comparison-group study. J Bone Joint Surg. 2000;82:1552-7.
4. Shi Z, Neoh KG, Kang ET, Wang W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials. 2006;27(11):2440-9. (Pubitemid 41821823)
5. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-71. (Pubitemid 47598444)
6. Moyad TF, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics. 2008;31(6):581-8. (Pubitemid 352007182)
7. Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, Kaye KS. Surgical site infection in the elderly following orthopaedic surgery. J Bone Joint Surg. 2006;88:1705-12. (Pubitemid 44200207)
8. Lee JH, Wang H, Kaplan JB, Lee WY. Microfluidic approach to create 3D tissue models for biofilm-related infection of orthopaedic implants. Tissue Eng Part C Methods. 2010.
9. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;27(11):2331-9. (Pubitemid 41821812)
10. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 2010;59:227-38.
11. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35:780-9. (Pubitemid 44286273)
12. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;27:2331-9. (Pubitemid 41821812)
13. Zhao L, Chu PK, Zhang Y, Wu Z. Antibacterial coatings on titanium implants. J Biomed Mater Res. 2009;91B:470-80.
14. Gillespie WJ, Walenkamp GH. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev. 2010;3:CD000244.
15. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med. 2005; 118(12):1416.
16. Bliziotis IA, Ntziora F, Lawrence KR, Falagas ME. Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials. Eur J Clin Microbiol Infect Dis. 2007;26(12):849-56. doi:10.1007/s10096-007-0378-1. (Pubitemid 350089877)
17. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006;19(4):349-56. (Pubitemid 43982507)
18. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. Acta Orthop Scand. 2001;72: 557-71. (Pubitemid 34031652)
19. Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH. Inhibition of implant-associated infections via nitric oxide release. Biomaterials. 2005;26(34):6984-90. (Pubitemid 41095521)
20. Ko EK, Jeong SI, Rim NG, Lee YM, Shin H, Lee BK. In vitro osteogenic differentiation of human mesenchymal stem cells and in vivo bone formation in composite nanofiber meshes. Tissue Eng Part A. 2008;14(12):2105-19.
21. Ruckh TT, Kumar K, Kipper MJ, Popat KC. Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. Acta Biomater. 2010;6(8):2949-59.
22. Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003;24(12):2077-82. (Pubitemid 36298779)
23. Sill TJ, von Recum HA. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials. 2008;29(13):1989-2006.
24. Choi JS, Leong KW, Yoo HS. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials. 2008;29(5): 587-96. (Pubitemid 350100803)
25. Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 2009;5(7): 2570-8. doi:10.1016/j.actbio.2008.12.013.
26. Hartman O, Zhang C, Adams EL, Farach-Carson MC, Petrelli NJ, Chase BD, et al. Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Biomaterials. 2010;31(21):5700-18.
27. Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide) -based electrospun nanofibrous scaffolds. J Control Release. 2004;98(1):47-56. (Pubitemid 38881606)
28. de Vries LE, Vallès Y, Agersø Y, Vaishampayan PA, García- Montaner A, Kuehl JV, et al. The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS ONE. 2011;6(6):e21644.
29. Guarino V, Taddei P, Di Foggia M, Fagnano C, Ciapetti G, Ambrosio L. The influence of hydroxyapatite particles on in vitro degradation behaviour of Pcl based composite scaffolds. Tissue Eng Part A. 2009;15:3655-68.
30. Ritger P, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, and cylinders or discs. J Control Release. 1987;5:23-36. (Pubitemid 17106643)
31. Sinclair G, Peppas N. Analysis of non-Fickian transport in polymers using simplified exponential expressions. J Membr Sci. 1984;17:329-31.
32. Lavicky J, Urbanova Z, Raskova H, Rotta J, Vanecek J. The effects of peptidoglycan, a pyrogenic constituent of gram-positive microorganisms, on the pharmacokinetics of rifampicin. Toxicon. 1988;26(3):293-300.
33. Pohlod DJ, Saravolatz LD, Somerville MM. In vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother. 1987;20(2): 197-202. (Pubitemid 17140398)
34. Hoshino A, Isono Y. Degradation of aliphatic polyester films by commercially available lipases with special reference to rapid and complete degradation of poly(L-lactide) film by lipase PL derived from Alcaligenes sp. Biodegradation. 2002;13(2):141-7. (Pubitemid 35257062)
35. Zeng J, Chen X, Liang Q, Xu X, Jing X. Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers. Macromol Biosci. 2004;4(12):1118-25. (Pubitemid 40095215)
36. Pitt C, Gratzl M, Kimmel C, Surles J, Schindler A. Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsiloncaprolactone), and their copolymers in vivo. Biomaterials. 1981;2(4):215-20. (Pubitemid 12195194)
37. Pulkkinen M, Malin M, Tarvainen T, Saarimäki T, Seppälä J, Järvinen K. Effects of block length on the enzymatic degradation and erosion of oxazoline linked poly-e-caprolactone. Eur J Pharm Sci. 2007;31(2):119-28. (Pubitemid 46660581)
38. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res. 1997;36(1):17-28. (Pubitemid 27270994)
39. Bashur CA, Dahlgren LA, Goldstein AS. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(D, L-lactic-co-glycolic acid) meshes. Biomaterials. 2006;27(33):5681-8. (Pubitemid 44279062)
40. Venugopal J, Prabhakaran MP, Low S, Choon AT, Deepika G, Dev VR, et al. Continuous nanostructures for the controlled release of drugs. Curr Pharm Des. 2009;15(15):1799-808.
41. Bjerketorp J, Jacobsson K, Frykberg L. The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett. 2004;234(2):309-14. (Pubitemid 38595648)
42. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 2010;6(8):e1001036.
43. Liu L, Xu Y, Shea C, Fowler JS, Hooker JM, Tonge PJ. Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem. 2010;53(7):2882-91.
44. Frippiat F, Meunier F, Derue G. Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. J Antimicrob Chemother. 2004;54(6):1158. (Pubitemid 40142601)
45. Pohlod DJ, Saravolatz LD, Somerville MM. In vitro susceptibility of Gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother. 1987;20:197-202. (Pubitemid 17140398)
46. Tupin A, Gualtieri M, Roquet-Baneres F, Morichaud Z, Brodolin K, Leonetti JP. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int J Antimicrob Agents. 2010;35(6):519-23.
47. Jatsenko T, Tover A, Tegova R, Kivisaar M. Molecular characterization of Rifr mutations in Pseudomonas aeruginosa and Pseudomonas putida. Mutation Res. 2010;683:106-14.
48. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645-54.
49. Xing Z-C, Chae W-P, Baek J-Y, Choi M-J, Jung Y, Kang I-K. In vitro assessment of antibacterial activity and cytocompatibility of silver-containing PHBV nanofibrous scaffolds for tissue engineering. Biomacromolecules. 2010;11:1248-53.
50. Liu X, Lin T, Fang J, Yao G, Zhao H, Dodson M, et al. In vivo wound healing and antibacterial performances of electrospun nanofibre membranes. J Biomed Mater Res. 2010;94A:499-508.